Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429052 · ClinicalTrials.gov registry record
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 24
- Enrollment target
NCT00429052 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 24 participants.
The verdict
NCT00429052 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The main objectives of this study are define frequency of plaque shift phenomenon and impact on flow dynamics in the side branch as assessed by intravascular ultrasound, and evaluate acute and late side branch ostial vessel reaction to balloon angioplasty and drug-eluting stents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429052
The ClinicalTrials.gov registry entry for NCT00429052 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00429052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429052 about?
NCT00429052 is a clinical study titled "Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease". The main objectives of this study are define frequency of plaque shift phenomenon and impact on flow dynamics in the side branch as assessed by intravascular ultrasound, and evaluate acute and late side branch ostial vessel reaction to balloon angioplasty and drug-eluting stents.
What is the current status of trial NCT00429052?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2006-11. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00429052?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.